life science investing Defence's Novel Accum-mRNA Vaccine Now Administered for Testing on Cancer 17 April 2023
life science investing RETRANSMISSION: Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins 11 April 2023
life science investing Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins 10 April 2023
